Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Aurora Cannabis Reports After The Bell; Trulieve Expands; Hexo Keeps Flailing

By Investing.com (Brenda O'Farrell/Investing.com)Stock MarketsSep 22, 2020 11:24
uk.investing.com/analysis/aurora-cannabis-reports-after-the-bell-trulieve-expands-hexo-keeps-flailing-200447091
Aurora Cannabis Reports After The Bell; Trulieve Expands; Hexo Keeps Flailing
By Investing.com (Brenda O'Farrell/Investing.com)   |  Sep 22, 2020 11:24
Saved. See Saved Items.
This article has already been saved in your Saved Items
 

For most market sectors, a company’s earnings report enables investors to assess its performance and measure of how management has done. And for that reason, these reports are awaited with great anticipation.

However, in the cannabis sector, earnings releases are sometimes viewed a little differently. Case in point: Aurora Cannabis (NYSE:ACB), (TSX:ACB).

When the Edmonton-based company posts its results after the closing bell later today, the information will be used to assess just how well the company managed expectations. That alone is what investors will be reacting to.

The main financial headlines about the marijuana grower’s fourth quarter results are already known, even though they have yet to be officially reported. This is one way to avoid the shock of bad news—break it gently to investors.

The results were essentially revealed a few weeks ago when the company announced its new CEO, Miguel Martin. Aurora used the occasion to share news it would also be taking a C$1.8 billion (US$1.368 billion) write-down. This is in addition to a previous $1 billion write-down it had taken earlier in the year.

The only metric still awaited with anticipation will be sales growth. But from a strategic point of view, investors are eager to learn any details about Aurora's plan to push further into the U.S. market. This is where the company holds onto hope that it will be able to turn its numbers around.

Aurora Weekly
Aurora Weekly

As other Canadian-based cannabis companies have looked to boost revenues in the derivative markets—what is commonly referred to as the 2.0 products—Aurora has opted to focus its attention on U.S. markets. How quickly it can turn that strategy into sales is not entirely clear.

Trulieve Broadens Its Footprint

Florida-based cannabis company Trulieve Cannabis (OTC:TCNNF), (CSE:TRUL) last week announced it is going to expand its footprint in the U.S., with the purchase of two marijuana companies in Pennsylvania: PurePenn and Solevo Wellness.

The deal for PurePenn, a grower and processor of medical marijuana licensed by the Pennsylvania Department of Health, includes a payment of US$46 million—US$27 million in Trulieve stock and US$19 million in cash, with potentially an additional US$60 million if certain financial targets are hit.

Trulieve has agreed to pay US$20 million for Solevo, which operates three medical marijuana dispensaries in Pittsburgh, split equally in cash and shares, with a possible additional payment of $15 million upon hitting agreed to financial benchmarks.

While shares of Trulieve have dropped about 11% since the deal was announced, their value has increased more than 110% in the last year.

Truileve Weekly
Truileve Weekly

Hexo Continues To Disappoint

For business marketing highs, the legal marijuana trade has not produced too many in the past year. In the absence of positive news, analysts have been looking for the next best thing – signs of good news. Even in this category, one Canadian-based cannabis grower continues to disappoint—Hexo (NYSE:HEXO), (TSX:HEXO).

Yesterday, shares of the Ottawa-based cannabis corporation closed down just over 8%, as it continues to struggle to find footing. Hoping to send an uplifting signal last week, HEXO announced the appointment of a new chief financial officer.

But the move fell flat as analysts were unimpressed. One reason: it's the company’s fourth CFO to be named in the last year.

Hexo Weekly
Hexo Weekly

The new CFO is Trent MacDonald, a former executive with pharmacy chain Rx Drug Mart, Canadian book retailer Indigo (TSX:IDG) and grocery chain Sobeys.

Another reason the news failed to impress was outlined by Jefferies analyst Owen Bennett, who pointed to MacDonald’s lack of experience in the global consumer goods space. As Bennett said, the choice does not inspire confidence.

In the last year, Hexo shares have lost more than 80% of their value.

Aurora Cannabis Reports After The Bell; Trulieve Expands; Hexo Keeps Flailing
 

Related Articles

Neil Wilson
Mixed Start For Stocks As UK Reopens By Neil Wilson - May 17, 2021

Reopening day in Britain – today is a big step forward for the economy, not so big for the stock market. Markets move well in advance, of course. Reopening trades have performed...

Aurora Cannabis Reports After The Bell; Trulieve Expands; Hexo Keeps Flailing

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
or
Sign up with Email